Thieme E-Books & E-Journals -
Pharmacopsychiatry, Table of Contents
Pharmacopsychiatry 2021; 54(03): 142-143
DOI: 10.1055/a-1408-8298
Letter to the Editor

Are Persons Treated with Antidepressants and/or Antipsychotics Possibly Better Protected against Severe COVID 19?

Authors

  • Udo Bonnet

    1   Department of Psychiatry, Psychotherapy, and Psychosomatic Medicine, Evangelisches Krankenhaus Castrop-Rauxel, Academic Teaching Hospital of the University of Duisburg-Essen, Essen, Germany
    2   LVR-Hospital Essen, Department of Psychiatry and Psychotherapy, Medical Faculty, University of Duisburg-Essen, Essen, Germany

  • Georg Juckel

    3   Department of Psychiatry, Ruhr University Bochum, LWL University Hospital, Bochum, Germany

  • Norbert Scherbaum

    2   LVR-Hospital Essen, Department of Psychiatry and Psychotherapy, Medical Faculty, University of Duisburg-Essen, Essen, Germany

  • Martin Schaefer

    4   Department of Psychiatry, Psychotherapy, Psychosomatics and Addiction Medicine, Evang. Kliniken Essen-Mitte, Essen, Germany
    5   Department of Psychiatry and Psychotherapy, Charité Campus Mitte, Charité-Universitätsmedizin Berlin, Germany

  • Bernhard Kis

    6   Department of Psychiatry, Psychotherapy and Psychosomatics, St. Elisabeth Hospital Niederwenigern, Contilia Group, Hattingen, Germany
    7   Department of Psychiatry and Psychotherapy, University Medical Center, Göttingen, Germany

  • Simon Cohen

    8   Klinik für Psychiatrie, Psychotherapie und Gerontopsychiatrie, HELIOS Marien Klinik, Duisburg, Germany

  • Jens Kuhn

    9   Department of Psychiatry and Psychotherapy, University Hospital Cologne, Cologne, Germany
    10   Department of Psychiatry, Psychotherapy, and Psychosomatic Medicine, Johanniter Hospital Oberhausen, Oberhausen, Germany
eRefRecommend Article